Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03588182 · ClinicalTrials.gov registry record · NA
Virtual Reality for External Cephalic Version
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03588182 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 5 participants.
The verdict
NCT03588182, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This will be a parallel design, nonblinded, randomized controlled superiority trial investigating the utility of a virtual reality (VR) experience to provide analgesia for external cephalic version (ECV).
Interventions
- OTHER Virtual Reality Experience
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-05-18 |
| Est. Completion | 2023-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03588182
The ClinicalTrials.gov registry entry for NCT03588182 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Experience is the first listed.
NCT03588182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03588182 about?
NCT03588182 is a clinical study titled "Virtual Reality for External Cephalic Version". This will be a parallel design, nonblinded, randomized controlled superiority trial investigating the utility of a virtual reality (VR) experience to provide analgesia for external cephalic version (ECV).
What is the current status of trial NCT03588182?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-05-18. Estimated completion is 2023-12-06.
What interventions are being tested in trial NCT03588182?
The interventions under investigation include: Virtual Reality Experience (OTHER).
Who is sponsoring clinical trial NCT03588182?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.